|
ZCRB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.551400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.695770E-01 |
| Normal-vs-Stage2 |
7.665400E-01 |
| Normal-vs-Stage3 |
5.296800E-01 |
| Normal-vs-Stage4 |
6.581000E-01 |
| Stage1-vs-Stage2 |
5.900600E-01 |
| Stage1-vs-Stage3 |
7.648800E-01 |
| Stage1-vs-Stage4 |
8.084000E-02 |
| Stage2-vs-Stage3 |
8.338000E-01 |
| Stage2-vs-Stage4 |
5.326200E-01 |
| Stage3-vs-Stage4 |
3.460000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.615400E-01 |
| Normal-vs-AfricanAmerican |
7.582900E-04 |
| Normal-vs-Asian |
1.483590E-02 |
| Caucasian-vs-AfricanAmerican |
4.583100E-04 |
| Caucasian-vs-Asian |
9.916200E-03 |
| AfricanAmerican-vs-Asian |
4.481600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.500400E-01 |
| Normal-vs-Female |
3.535000E-01 |
| Male-vs-Female |
7.574000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.197200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.257400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.947600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.376400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.290000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.457200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.047200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.895370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.332000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.303400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.199230E-01 |
| Normal-vs-Grade 2 |
7.225800E-01 |
| Normal-vs-Grade 3 |
2.151200E-01 |
| Normal-vs-Grade 4 |
6.166200E-01 |
| Grade 1-vs-Grade 2 |
1.046950E-01 |
| Grade 1-vs-Grade 3 |
2.584400E-01 |
| Grade 1-vs-Grade 4 |
1.685960E-01 |
| Grade 2-vs-Grade 3 |
3.482400E-01 |
| Grade 2-vs-Grade 4 |
8.494200E-01 |
| Grade 3-vs-Grade 4 |
5.450800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.812200E-01 |
| Normal-vs-ccB subtype |
6.242800E-01 |
| ccA subtype-vs-ccB subtype |
8.637200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.264800E-01 |
| Normal-vs-N1 |
6.764000E-01 |
| N0-vs-N1 |
7.391800E-01 |
|
|
